Star Sports Medicine Co., Ltd. will convene its 2025 annual shareholders’ meeting at 10:00 a.m. on 26 June 2026 in the Weilaige Conference Room, ZKML Building, Beijing. Holders of H shares may attend in person or vote by proxy.

Key ordinary resolutions: • Board of Directors’ and Board of Supervisors’ work reports for FY-2025. • Final accounts, audited financial statements and the accountants’ report for FY-2025. • FY-2026 financial budget. • FY-2025 profit-distribution proposal. • Re-appointment of Ernst & Young Hua Ming LLP as financial auditor for FY-2026. • 2026 remuneration and allowances for executive and non-executive directors, senior management and independent non-executive directors.

Key special resolutions: • Proposed abolition of the Board of Supervisors. • Amendments to the Articles of Association and Rules of Procedure (shareholders’ meeting and board of directors). • General mandates to repurchase H shares and to issue shares.

Proxy arrangements: completed proxy forms and relevant authorisations must reach Computershare Hong Kong Investor Services Limited no later than 10:00 a.m. on 25 June 2026. Identification documents are required for meeting admission.